We are monitoring the impact of COVID-19 on Continuous Glucose Monitoring Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 9127
Share on
Share on

Global Continuous Glucose Monitoring Market Size, Share, Trends & Growth Analysis Report – Segmented By Components Type, End Users & Region (North America, Europe, APAC, LATAM, and MEA) – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 9127
Pages: 160

CGM Market Size (2020 to 2025)

The global continuous glucose monitoring market size was worth USD 3842 Million in 2019 and is forecasted to grow at a CAGR of 25.6% from 2020 to 2025.

Continuous glucose monitoring is an advanced medical technology for people with diabetes to check over their glucose levels for a particular period.

The continuous glucose monitoring market has grown widely across the world. Millions of people who are diabetic patients use these CGM to check the correct readings of blood glucose levels. The CGM devices also help diabetic patients to decrease the insulin dosage. The interpretations of these CGM devices will transmit to the receivers through a wireless network. They keep track of the readings over time, identifying minute changes in the BGM by preventing hypoglycaemic conditions. 

Higher-order inside the industry for glucose monitoring has been building on advancements in the production and manufacturing monitoring medical devices and products. This glucose level in the blood is an essential parameter for diagnosing and treating several diseases and infections. Due to the knowledge, healing practitioners and doctors mostly purchase and manage glucose monitoring devices to track patients' health. Glucose monitoring leads to the production of tools and equipment that assist in real-time monitoring and sensing glucose levels in this family. The head of the pieces to do minimally invasive medical media has also provided an incentive to most of the global continuous glucose monitoring market in recent times.

The increasing incidence of diabetes is a critical factor that could revolutionize the growth dynamics of the worldwide Continuous Glucose Monitoring Market. People whose plasma glucose levels undergo regular changes generally use glucose monitoring devices, increasing market demand. In the present scenario, most of the diabetic population are using insulin pumps alongside CGM devices in their diabetic treatment procedure, which is further expected to accelerate the growth of the market. As per the International Diabetes Federation, in 2019, the population affected by diabetes was 463 million, of which 4.2 million people dead. This figure is estimated to reach 530 million by 2030 and 700 million by 2045. 

Some specific products of this domain are growing at a good pace in the global market for continuous glucose monitoring. Moreover, protector real-time CGM systems have been bringing a tremendous demand toward other glucose monitoring systems over the past decade. The need for continuous glucose monitoring market has been the biggest amongst people living with diabetes. This factor is forecasted to become more apparent over the coming years as the prevalence of diabetes increases across the globe.

Impact of COVID-19 on the global continuous glucose monitoring market:

COVID 19 pandemic has favored a few healthcare industry sectors, and the continuous glucose monitoring sector is one among them. Upon receiving the boost from the COVID-19, the market of continuous glucose monitoring market is forecasted to rise even more aggressively during the forecast period.

Most of the people diagnosed and admitted with COVID-19 in hospitals are majorly diabetic people. These diabetic patients need continuous glucose monitoring effectively in hospitals, which is directly favoring market growth. Patients with diabetes and diagnosed with COVID-19 are at a greater risk of death and which already had happened to a few of the people around the world.

The U.S. FDA agency approved and enabled two CGM devices, namely Dexcom G6 and Abbott Freestyle Libre, for hospitals. Scripps Health launched a wireless device Dexcom G6 to decrease the contact with the COVID-19 patients.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Component, End User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Challenges, Restraints, Opportunities, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global continuous glucose monitoring market has been segmented and sub-segmented based on component type, end-user, and region.

Continuous Glucose Monitoring Market – By Component Type:

The sensors segment is likely to account for the most substantial share market value based on the component type. These sensors use glucose oxidase to examine blood sugar levels. It is due to the conversion of glucose into hydrogen peroxide by glucose oxidase. Increasing geriatric population to fuel the demand for this segment. 

Continuous Glucose Monitoring Market – By End User:

  • Hospitals
  • Homecare Diagnostics
  • Others

Based on the end-user, the Homecare diagnostics hold the highest share value. These homecare devices provide patients with less insulin dosage consumption and help in monitoring glucose levels accurately. This homecare device is likely to grow the market value due to its maximum productivity. 

Continuous Glucose Monitoring Market – By Region:

  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • United Kingdom
    • France
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • South Korea
    • Australia
    • New Zealand
    • Rest of APAC
  • Latin America
    • Brazil
    • Argentina
    • Chile
    • Rest of Latin America
  • Middle East
  • Africa

Regionally, the North American CGM market is dominating the global CGM market. With over 90% of the share, the United States ruling the market in North America. This healthcare organization in Canada and the US has undoubtedly outdone all other regions' healthcare divisions across the globe. The usage of continuous glucose monitoring practices in these nations has also become a leap in recent times. Furthermore, North American characters' lazy and improper lifestyles have presented rise to several diseases or disorders such as diabetes and high blood pressure. Owing to the circumstances mentioned above, this market inside the search for connected glucose monitoring in North America has been rising at an astronomical rate in recent times.

Followed by North America, this industry for compatible glucose monitoring in Europe has developed at a healthy pace over the preceding several years. It owes to the presence of a knowledgeable medical practitioner that can suggest the right products for continuous glucose monitoring to the masses.

NOTABLE PLAYERS IN THIS MARKET:

Key market participants leading the global continuous glucose monitoring market profiled in this report are Dexcom Inc., Roche Diagnostics, Medtronic plc., Novo Nordisk, Abbott Laboratories, Animas Corporation, Ypsomed AG., Bayer AG, Insulet Corporation, and Sensonic Corporation.

MAJOR HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

  • On February 21, 2020, Dexcom has announced that it has gained a CE mark for its G6 continuous glucose monitoring, where it can be used safely over pregnant women. Dexcom is behind the pregnancy patients as it looks after the patients with Type 1 and Type 2. The company is expanding its patient pregnancy population for its signature device.
  • On September 17, 2019, Medtronic introduced a new system called Envision Pro for the continuous monitoring system. It can be thrown away after use, and zero calibration CGM system. This technology is to give accurate results while checking type I and type ll diabetes patients. 
  • On October 01, 2018, Novo Nordisk made a public statement that it will launch connected insulin pens for patients who have diabetes. These insulin pens will be able to share information or ideas with CGM and (BGM) blood glucose monitoring systems. It is a very long awaiting program as researchers are trying to launch smart insulin pens.
  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Component Type
      1. Transmitters & Receivers
      2. Sensors
      3. Insulin Pumps
      4. Y-o-Y Growth Analysis, By Component Type
      5. Market Attractiveness Analysis, By Component Type
      6. Market Share Analysis, By Component Type
    2. By End User
      1. Hospitals
      2. Homecare Diagnostics
      3. Others
      4. Y-o-Y Growth Analysis, By Form
      5. Market Attractiveness Analysis, By Form
      6. Market Share Analysis, By Form
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Component Type
        3. By Form
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Component Type
        3. By Form
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Component Type
        3. By Form
    2. North America
      1. Introduction
      2. US
      3. Canada
    3. Europe
      1. Introduction
      2. UK
      3. France
      4. Spain
      5. Germany
      6. Italy
    4. Asia-Pacific
      1. Introduction
      2. India
      3. China
      4. Japan
      5. South Korea
      6. Australia
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
    6. Middle East & Africa
      1. Introduction
      2. Middle East
      3. Africa
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Dexcom Inc.
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Roche Diagnostics
    3. Medtronic plc.
    4. Novo Nordisk
    5. Abbott Laboratories
    6. Animas Corporation
    7. Ypsomed AG.
    8. Bayer AG
    9. Insulet Corporation
    10. Sensonic Corporation
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type and Technology along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Continuous Glucose Monitoring Market, By Region, From 2020 to 2025 (USD Million)
  2. Global Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  3. Global Transmitters & Receivers Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Sensors Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Insulin Pumps Market, By Region, From 2020 to 2025 (USD Million)
  6. Global Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  7. Global Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  8. Global Homecare Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  9. Global Others Market, By Region, From 2020 to 2025 (USD Million)
  10. North America Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  11. North America Transmitters & Receivers Market, By Region, From 2020 to 2025 (USD Million)
  12. North America Sensors Market, By Region, From 2020 to 2025 (USD Million)
  13. North America Insulin Pumps Market, By Region, From 2020 to 2025 (USD Million)
  14. North America Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  15. North America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  16. North America Homecare Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  17. North America Others Market, By Region, From 2020 to 2025 (USD Million)
  18. United States Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  19. United States Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  20. Canada Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  21. Canada Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  22. Europe Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  23. Europe Transmitters & Receivers Market, By Region, From 2020 to 2025 (USD Million)
  24. Europe Sensors Market, By Region, From 2020 to 2025 (USD Million)
  25. Europe Insulin Pumps Market, By Region, From 2020 to 2025 (USD Million)
  26. Europe Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  27. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  28. Europe Homecare Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  29. Europe Others Market, By Region, From 2020 to 2025 (USD Million)
  30. U.K. Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  31. U.K. Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  32. Germany Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  33. Germany Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  34. France Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  35. France Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  36. Italy Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  37. Italy Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  38. Spain Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  39. Spain Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  40. Asia Pacific Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  41. Asia Pacific Transmitters & Receivers Market, By Region, From 2020 to 2025 (USD Million)
  42. Asia Pacific Sensors Market, By Region, From 2020 to 2025 (USD Million)
  43. Asia Pacific Insulin Pumps Market, By Region, From 2020 to 2025 (USD Million)
  44. Asia Pacific Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  45. Asia Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  46. Asia Pacific Homecare Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  47. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Million)
  48. Japan Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  49. Japan Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  50. China Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  51. China Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  52. India Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  53. India Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  54. Australia Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  55. Australia Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  56. South Korea Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  57. South Korea Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  58. Latin America Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  59. Latin America Transmitters & Receivers Market, By Region, From 2020 to 2025 (USD Million)
  60. Latin America Sensors Market, By Region, From 2020 to 2025 (USD Million)
  61. Latin America Insulin Pumps Market, By Region, From 2020 to 2025 (USD Million)
  62. Latin America Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  63. Latin America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  64. Latin America Homecare Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  65. Latin America Others Market, By Region, From 2020 to 2025 (USD Million)
  66. Brazil Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  67. Brazil Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  68. Argentina Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  69. Argentina Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  70. Mexico Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  71. Mexico Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  72. Rest of Latin America Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  73. Rest of Latin America Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  74. Middle East and Africa Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  75. Middle East and Africa Transmitters & Receivers Market, By Region, From 2020 to 2025 (USD Million)
  76. Middle East and Africa Sensors Market, By Region, From 2020 to 2025 (USD Million)
  77. Middle East and Africa Insulin Pumps Market, By Region, From 2020 to 2025 (USD Million)
  78. Middle East and Africa Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  79. Middle East and Africa Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  80. Middle East and Africa Homecare Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  81. Middle East and Africa Others Market, By Region, From 2020 to 2025 (USD Million)
  82. Middle East Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  83. Middle East Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)
  84. Africa Continuous Glucose Monitoring Market, By Component Type, From 2020 to 2025 (USD Million)
  85. Africa Continuous Glucose Monitoring Market, By End User, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample